Featured Research

from universities, journals, and other organizations

Whooping cough has lifelong health impact, study finds

Date:
June 18, 2013
Source:
Lund University
Summary:
People born during whooping cough outbreaks are more likely to die prematurely even if they survive into adulthood, new research has found. Women had a 20% higher risk of an early death, and men a staggering 40%. Women also suffered more complications during and after pregnancy, with an increased risk of miscarriage as well as infant death within the first month of life.

People born during whooping cough outbreaks are more likely to die prematurely even if they survive into adulthood, research at Lund University in Sweden has found. Women had a 20% higher risk of an early death, and men a staggering 40%. Women also suffered more complications during and after pregnancy, with an increased risk of miscarriage as well as infant death within the first month of life.

"The results show the importance of following up patients with exposure to whooping cough in childhood, particularly pregnant women," says Luciana Quaranta, the PhD candidate at Lund University behind the findings.

The landmark study used a globally unique database, the Scanian Economic Demographic Database, based on data from Sweden's extensive population registers. Quaranta mapped five communities between 1813 and 1968, in an effort to understand how conditions at birth, such as socioeconomic status and exposure to infectious diseases, affect us later in life.

Whooping cough, or pertussis, was widely considered to have been all but eradicated in many developed countries until recently. The UK, the US and Australia have all seen outbreaks of the disease in the past two years.


Story Source:

The above story is based on materials provided by Lund University. Note: Materials may be edited for content and length.


Cite This Page:

Lund University. "Whooping cough has lifelong health impact, study finds." ScienceDaily. ScienceDaily, 18 June 2013. <www.sciencedaily.com/releases/2013/06/130618101612.htm>.
Lund University. (2013, June 18). Whooping cough has lifelong health impact, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/06/130618101612.htm
Lund University. "Whooping cough has lifelong health impact, study finds." ScienceDaily. www.sciencedaily.com/releases/2013/06/130618101612.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins